Synthesis of some new pyrazolone derivatives as potent antimicrobial agents
| dc.contributor.author | Vijesh, A.M. | |
| dc.contributor.author | Isloor, A.M. | |
| dc.contributor.author | Isloor, S. | |
| dc.contributor.author | Shivananda, K.N. | |
| dc.contributor.author | Shyma, P.C. | |
| dc.contributor.author | Arulmoli, T. | |
| dc.date.accessioned | 2026-02-05T09:35:39Z | |
| dc.date.issued | 2011 | |
| dc.description.abstract | Invasive microbial infections are major problems around the world, especially in immuno compromised patients. The recent expansion of antimicrobial drug research has occurred because there is a critical need for new antimicrobial agents to treat these life threatening invasive infections. In the present study three series of new substituted pyrazolone derivatives (5a-f, 6a-f and 8a,b) were synthesized by the Knoevenagel condensation reaction of pyrazolones (3a,b) with various substituted carbaldehydes (4a-f, 7). These newly synthesized compounds were characterized by IR, NMR, mass spectra and also by C, H, N analyses. New compounds were screened for their antimicrobial studies against S. aureus, B. subtilis, E. coli and P. aeruginosa. The results revealed that compounds 5c and 6c having 2,5-dichlorothiophene substituent showed significant antibacterial activity against all tested microorganisms as compared to the standard drug Ceftriaxone. | |
| dc.identifier.citation | Der Pharma Chemica, 2011, 3, 4, pp. 454-463 | |
| dc.identifier.uri | https://idr.nitk.ac.in/handle/123456789/27182 | |
| dc.subject | 2 (2,4 dinitrophenyl) 4 [(6 methoxynaphthalen 2 yl)methylidene] 5 methyl 2,4 dihydro 3h pyrazol 3 one | |
| dc.subject | 2 (2,4 dinitrophenyl) 4 [[3 (4 methoxyphenyl) 1h pyrazol 4 yl]methylidene] 5 methyl 2,4 dihydro 3h pyrazol 3 one | |
| dc.subject | 2 (2,4 dinitrophenyl) 5 methyl 4 [[3 [4 (methylsulfanyl)phenyl] 1h pyrazol 4 yl]methylidene] 2,4 dihydro 3h pyrazol 3 one | |
| dc.subject | 4 [(6 methoxynaphthalen 2 yl)methylidene] 5 methyl 2 phenyl 2,4 dihydro 3h pyrazol 3 one | |
| dc.subject | 4 [[3 (2,4 dichlorophenyl) 1h pyrazol 4 yl]methylidene] 5 methyl 2 phenyl 2,4 dihydro 3h pyrazol 3 one | |
| dc.subject | 4 [[3 (2,5 dichlorothiophen 3 yl) 1h pyrazol 4 yl]methylidene] 2 (2,4 dinitrophenyl) 5 methyl 2,4 dihydro 3h pyrazol 3 one | |
| dc.subject | 4 [[3 (2,5 dichlorothiophen 3 yl) 1h pyrazol 4 yl]methylidene] 5 methyl 2 phenyl 2,4 dihydro 3h pyrazol 3 one | |
| dc.subject | 4 [[3 (4 biphenyl) 1h pyrazol 4 yl]methylidene] 2 (2,4 dinitrophenyl) 5 methyl 2,4 dihydro 3h pyrazol 3 one | |
| dc.subject | 4 [[3 (4 biphenyl) 1h pyrazol 4 yl]methylidene] 5 methyl 2 phenyl 2,4 dihydro 3h pyrazol 3 one | |
| dc.subject | 4 [[3 (4 chlorophenyl) 1h pyrazol 4 yl]methylidene] 2 (2,4 dinitrophenyl) 5 methyl 2,4 dihydro 3h pyrazol 3 one | |
| dc.subject | 4 [[3 (4 chlorophenyl) 1h pyrazol 4 yl]methylidene] 5 methyl 2 phenyl 2,4 dihydro 3h pyrazol 3 one | |
| dc.subject | 4 [[3 (4 methoxyphenyl) 1h pyrazol 4 yl]methylidene] 5 methyl 2 phenyl 2,4 dihydro 3h pyrazol 3 one | |
| dc.subject | 5 methyl 4 [[3 [4 (methylsulfanyl)phenyl] 1h pyrazol 4 yl]methylidene] 2 phenyl 2,4 dihydro 3h pyrazol 3 one | |
| dc.subject | antibiotic agent | |
| dc.subject | ceftriaxone | |
| dc.subject | pyrazolone derivative | |
| dc.subject | unclassified drug | |
| dc.subject | antibacterial activity | |
| dc.subject | article | |
| dc.subject | Bacillus subtilis | |
| dc.subject | carbon nuclear magnetic resonance | |
| dc.subject | controlled study | |
| dc.subject | drug determination | |
| dc.subject | drug effect | |
| dc.subject | drug screening | |
| dc.subject | drug structure | |
| dc.subject | drug synthesis | |
| dc.subject | Escherichia coli | |
| dc.subject | infrared spectroscopy | |
| dc.subject | mass spectrometry | |
| dc.subject | minimum inhibitory concentration | |
| dc.subject | nitrogen nuclear magnetic resonance | |
| dc.subject | nonhuman | |
| dc.subject | proton nuclear magnetic resonance | |
| dc.subject | Pseudomonas aeruginosa | |
| dc.subject | Staphylococcus aureus | |
| dc.title | Synthesis of some new pyrazolone derivatives as potent antimicrobial agents |
